戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 K showed that the enzyme is not regulated by fructose 1,6 bisphosphate.
2 IA(Glc) (formerly known as III(glc)), and by fructose 1,6-bisphosphate.
3 cerone-P and glyceraldehyde 3-phosphate into fructose 1,6-bisphosphate.
4  exhibited an apparent K(m) of 35 microM for fructose 1,6-bisphosphate.
5 up to 3-fold, with no effect on the K(m) for fructose 1,6-bisphosphate.
6 tone phosphate, forming the much more stable fructose 1,6-bisphosphate.
7  expand the activator specificity to include fructose 1,6-bisphosphate.
8  H379K enzymes were found to be activated by fructose 1,6-bisphosphate.
9 e concentration of a key early intermediate, fructose 1,6-bisphosphate.
10 0.96 +/- 0.07 mm in the presence of Mn2+ and fructose 1,6-bisphosphate.
11 t to Mg2+, and uncompetitive with respect to fructose 1,6-bisphosphate.
12  activity toward inositol monophosphates and fructose 1,6-bisphosphate.
13 this inhibitor is derived from chloroplastic fructose 1,6-bisphosphate.
14 athway by converting fructose-6-phosphate to fructose-1,6-bisphosphate.
15 ion into the concentration of the metabolite fructose-1,6-bisphosphate.
16 rsible conversion of fructose-6-phosphate to fructose-1,6-bisphosphate.
17 T403E) abolishes activation of the enzyme by fructose-1, 6-bisphosphate.
18  above, exhibit kinetic parameters (K(m) for fructose-1,6-bisphosphate, 1.1-1.8 microm; K(a) for Mg(2
19  Ser61 to alanine increases the Km value for fructose 1, 6-bisphosphate 16-fold and product inhibitio
20 s work: a complex with a substrate analogue, fructose 1,6-bisphosphate, a complex with dihydroxyaceto
21 cose, binding of the known effector molecule fructose-1,6-bisphosphate abolishes this interaction.
22                             For this system, fructose-1,6-bisphosphate (activator) and alanine (inhib
23 e, and we can for the first time explain how fructose 1,6-bisphosphate affects the active site.
24  in the active site, many of which abolished fructose 1, 6-bisphosphate aldolase activity, no switch
25 evealed a specific interaction of GLUT4 with fructose 1, 6-bisphosphate aldolase.
26 comparable to the naturally occurring enzyme fructose 1,6 bisphosphate aldolase.
27                                The class IIa fructose 1,6-bisphosphate aldolase (FBA) enzyme from M.
28             Using the X-ray structure of the fructose 1,6-bisphosphate aldolase and multiple sequence
29 tion of fba and pyk, encoding, respectively, fructose 1,6-bisphosphate aldolase and pyruvate kinase,
30                                              Fructose 1,6-bisphosphate aldolase catalyses the reversi
31 t structure of the Escherichia coli Class II fructose 1,6-bisphosphate aldolase in the presence of th
32 cal substrates of AtLSMT-L are chloroplastic fructose 1,6-bisphosphate aldolase isoforms.
33 in attempts to switch the specificity of the fructose 1,6-bisphosphate aldolase to that of the tagato
34 nesis, including bifunctional unidirectional fructose 1,6-bisphosphate aldolase/phosphatase, have bee
35                              Loss of hepatic fructose-1, 6-bisphosphate aldolase B (Aldob) leads to a
36 e structure of the glycolytic enzyme class I fructose-1, 6-bisphosphate aldolase from the human malar
37 des for a 324-residue-long putative class II fructose-1, 6-bisphosphate aldolase.
38 e S-transferase (2gst), catalase (8act), and fructose-1,6-bisphosphate aldolase (1fba)].
39                The current model posits that fructose-1,6-bisphosphate aldolase (ALD) provides a crit
40 keletal muscle and yeast F-actin with muscle fructose-1,6-bisphosphate aldolase (aldolase) and glycer
41 hate (GAP), as it passes between the enzymes fructose-1,6-bisphosphate aldolase (aldolase) and glycer
42 cluding the zinc-dependent glycolytic enzyme fructose-1,6-bisphosphate aldolase (BB0445), the Borreli
43                                          The fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) homotet
44 to our interest in metallodependent class II fructose-1,6-bisphosphate aldolase (FBA-tb), a key enzym
45 tate or glycerol; these results suggest that fructose-1,6-bisphosphate aldolase (FbaA) is a target of
46                              Giardia lamblia fructose-1,6-bisphosphate aldolase (FBPA) is a member of
47           We present two examples in detail: fructose-1,6-bisphosphate aldolase and the mitogen-activ
48                                   Vertebrate fructose-1,6-bisphosphate aldolase exists as three isozy
49  report the crystal structures of glycosomal fructose-1,6-bisphosphate aldolase from two major tropic
50                  The structure of a class II fructose-1,6-bisphosphate aldolase in complex with the s
51 bisco, sedoheptulose-1,7-bisphosphatase, and fructose-1,6-bisphosphate aldolase were indicated.
52                                     Class II fructose 1,6-bisphosphate aldolases (FBP-aldolases) cata
53                                              Fructose-1, 6-bisphosphate aldolases (FBA) are cytoplasm
54 its evolutionary history from all eukaryotic fructose-1, 6-bisphosphate aldolases studied so far.
55                         Class I and class II fructose-1,6-bisphosphate aldolases (FBPA), glycolytic p
56  phosphoenolpyruvate (PEP) in the absence of fructose 1,6-bisphosphate, although PEP binding to enzym
57 e phosphatase contained increased amounts of fructose 1,6-bisphosphate and 2-carboxyarabinitol 1-phos
58 igher levels of the glycolytic intermediates fructose 1,6-bisphosphate and 3-phosphoglycerate, and hi
59 rrelated with respect to the two substrates, fructose 1,6-bisphosphate and fructose 1-phosphate.
60  relevant intracellular metabolites, such as fructose 1,6-bisphosphate and fructose 2,6-bisphosphate,
61                                              Fructose 1,6-bisphosphate and IMP together may be dynami
62 osterically activated by metabolites such as fructose 1,6-bisphosphate and inhibited by inorganic pho
63                                   The Km for fructose 1,6-bisphosphate and the Ki for the competitive
64 he wild-type enzyme is strongly activated by fructose-1,6-bisphosphate and weakly activated by both f
65                   Mg2+ cooperativity, Km for fructose 1,6-bisphosphate, and Ki for fructose 2,6-bisph
66 iosynthetic intermediates such as RuBP, ATP, fructose 1,6-bisphosphate, and NADPH enhanced DNA bindin
67 portant substrates, fructose 1-phosphate and fructose 1,6-bisphosphate, and provides an excellent mod
68 ed with the natural substrate of the enzyme, fructose 1,6-bisphosphate, and substantiated a previousl
69 e phosphate, glyceraldehyde 3-phosphate, and fructose 1,6-bisphosphate at 1.5, 2.1, and 1.3 A, respec
70 by thermostability studies, demonstrate that fructose 1,6-bisphosphate binding to the allosteric doma
71 f the tyrosyl-phosphorylated proteins at the fructose 1,6-bisphosphate-binding site converts the tetr
72 histidines and phosphate groups, mostly from fructose-1,6-bisphosphate but also inorganic phosphates
73                         The enzyme cleaves d-fructose-1,6-bisphosphate but not d-tagatose-1,6-bisphos
74 drolyze fructose-2,6-bisphosphate as well as fructose-1,6-bisphosphate but not fructose 6-phosphate i
75  mechanism of AMP inhibition with respect to fructose 1,6-bisphosphate changed from noncompetitive (w
76  allosteric mechanism whereby the binding of fructose 1,6-bisphosphate destabilizes an alpha-helix th
77                Thus, many have proposed that fructose-1,6-bisphosphate (F-1,6-BP) is also a physiolog
78 IN3D-depleted cells have increased levels of Fructose 1,6 Bisphosphate (F1,6-BP), the last six-carbon
79                                      Because fructose-1,6-bisphosphate (F1,6BP) shifts the metabolism
80 and all apicomplexans express one or both of fructose 1,6-bisphosphate (F16BP) aldolase and 2-deoxyri
81                     The allosteric activator fructose-1,6-bisphosphate [F16BP, AC50 (concentration th
82 miting step in the pathway and the levels of fructose (1,6) bisphosphate (FBP), are predictive of the
83 vity toward ATP and allosteric regulation by fructose 1, 6-bisphosphate (FBP), which has been shown t
84              We show that the PKM2 activator fructose 1,6-bisphosphate (FBP) alone promotes tetrameri
85 ls of dihydroxy-acetone phosphate (DHAP) and fructose 1,6-bisphosphate (FBP) and a progressive loss o
86                         First, we identified fructose 1,6-bisphosphate (FBP) as an in vivo sentinel m
87 ation by the glycolytic pathway intermediate fructose 1,6-bisphosphate (FBP) compared to wild-type GK
88                                At saturating fructose 1,6-bisphosphate (FBP) concentrations, Li+ was
89 ibitor oxalate, and the allosteric activator fructose 1,6-bisphosphate (FBP) has been determined to a
90 lase family that catalyzes the cleavage of d-fructose 1,6-bisphosphate (FBP) into dihydroxyacetone ph
91  For monitoring glycolysis, the intermediate fructose 1,6-bisphosphate (FBP) is a particularly inform
92                                              Fructose 1,6-bisphosphate (FBP) protects astrocytes from
93     The addition of the allosteric activator fructose 1,6-bisphosphate (FBP) to form the yPK-Tl+-Mn2+
94 lation of fructose 6-phosphate (F6P) to give fructose 1,6-bisphosphate (FBP) using MgATP as the phosp
95 yruvate (PEP), one of the two substrates, or fructose 1,6-bisphosphate (FBP), an activator.
96 licit major structural reorganization of the fructose 1,6-bisphosphate (FBP), an allosteric activator
97 ic pathway [e.g., phosphoenolpyruvate (PEP), fructose 1,6-bisphosphate (FBP), and citrate] and by the
98 as malate, ribulose 1,5-bisphosphate (RuBP), fructose 1,6-bisphosphate (FBP), and photorespiration in
99 otransferase) is inhibited allosterically by fructose 1,6-bisphosphate (FBP), and this inhibition is
100 f the allosteric regulators of its activity, fructose 1,6-bisphosphate (FBP), at 3.2 and 3.0 A, are p
101 nal approaches to investigate the effects of fructose 1,6-bisphosphate (FBP), phosphate (Pi), and ion
102 mined for myo-inositol 1-phosphate (IMP) and fructose 1,6-bisphosphate (FBP), previously considered t
103 lators, adenosine 5'-monophosphate (AMP) and fructose 1,6-bisphosphate (FBP), respectively.
104 ose pyrophosphorylase is mainly activated by fructose 1,6-bisphosphate (FBP), whereas the Agrobacteri
105 ule effectors, glucose 6-phosphate (G6P) and fructose 1,6-bisphosphate (FBP), which somehow enhance C
106  via autocatalytic activation by its product fructose 1,6-bisphosphate (FBP).
107 in the absence of the heterotropic activator fructose 1,6-bisphosphate (FBP).
108 and glyceraldehyde 3-phosphate (G3P) to form fructose 1,6-bisphosphate (FBP).
109                                              Fructose-1,6-bisphosphate (FBP) aldolase is an essential
110                                              Fructose-1,6-bisphosphate (FBP) aldolase, a glycolytic e
111 reduce affinity for the allosteric inhibitor fructose-1,6-bisphosphate (FBP) and formation of the tet
112                                              Fructose-1,6-bisphosphate (FBP) has been shown to attenu
113                          The neuroprotectant fructose-1,6-bisphosphate (FBP) preserves cellular [ATP]
114 in slice studies of hypoxia, with or without fructose-1,6-bisphosphate (FBP) pretreatment.
115  Bacteroides species show that ATP-dependent fructose-1,6-bisphosphate (FBP) synthesis is necessary f
116                                              Fructose-1,6-bisphosphate (FBP), an endogenous intermedi
117                                              Fructose-1,6-bisphosphate (FBP), an endogenous intracell
118  absence of the natural allosteric activator fructose-1,6-bisphosphate (FBP), maintained high tempera
119 phosphate (G6P), fructose-6-phosphate (F6P), fructose-1,6-bisphosphate (FBP), phosphoenolpyruvate (PE
120 rs AMPK activation by sensing the absence of fructose-1,6-bisphosphate (FBP), with AMPK being progres
121 sponse by binding to the allosteric site for fructose-1,6-bisphosphate (FBP).
122 ve (ultrasensitive) allosteric activation by fructose-1,6-bisphosphate (FBP).
123 : ATP 5, ADP 0.01, phosphocreatine (CrP) 10) fructose-1,6-bisphosphate (FBP; 1 mm) and fructose-6-pho
124 es for inhibitor alanine (Ala) and activator fructose-1,6-bisphosphate (Fru-1,6-BP) in human liver py
125 phosphorylation, and 3) prevented binding of fructose-1,6-bisphosphate (Fru-1,6-BP).
126         The aldolase substrates and product, fructose 1,6-bisphosphate, fructose 1-phosphate, and dih
127      In vivo phosphorylating agents, such as fructose 1,6-bisphosphate, generate phosphorylated forms
128 incorporate 14C from 14CO2 sequentially into fructose 1,6-bisphosphate, hamamelose bisphosphate, hama
129 tion leads to the continuous accumulation of fructose 1,6-bisphosphate in a permanently frozen soluti
130  glucose-labeling studies showed accumulated fructose 1,6-bisphosphate in FK866-treated cells mainly
131 endent conversion of fructose-6-phosphate to fructose-1,6-bisphosphate in glycolysis.
132                                 The K(m) for fructose 1,6-bisphosphate increased about 2-approximatel
133                                 In contrast, fructose 1,6-bisphosphate inhibition of glycerol kinase
134 y step in gluconeogenesis, the conversion of fructose 1,6-bisphosphate into fructose 6-phosphate.
135 n Mg(2+) for high activity, and that neither fructose-1,6-bisphosphate nor AMP was a positive alloste
136 glycolysis and the feedforward activation of fructose-1,6-bisphosphate on pyruvate kinase translate f
137  (EMSAs) confirmed a destabilizing effect of fructose-1,6-bisphosphate on the CggR/DNA complex, and a
138  by incubation with the aldolase substrates, fructose 1,6-bisphosphate or glyceraldehyde 3-phosphate.
139 ction into permeabilized 3T3L1 adipocytes of fructose 1,6-bisphosphate or the metabolic inhibitor 2-d
140 ites (such as dihydroxyacetone phosphate and fructose-1,6-bisphosphate), pentose phosphate pathway co
141 ontaining decreased amounts of chloroplastic fructose 1,6-bisphosphate phosphatase contained increase
142                                              Fructose 1,6-bisphosphate potently inhibits both isozyme
143 e key processes identified are metabolism of fructose-1,6-bisphosphate, production of glycerol-3-phos
144 presence of glycolytic intermediates such as fructose 1,6-bisphosphate (the intracellular effector),
145                                           As fructose-1, 6-bisphosphate, the product of PFK activity,
146                                              Fructose-1,6-bisphosphate then promotes Cdc19 tetrameriz
147 tochondrial PEP without producing glycolytic fructose 1,6-bisphosphate to allosterically activate PKm
148 step in gluconeogenesis is the conversion of fructose 1,6-bisphosphate to fructose 6-phosphate by a f
149  protein encoded by the ALDOA gene, converts fructose-1,6-bisphosphate to dihydroxyacetone phosphate
150 osphorylates fructose-6-phosphate to produce fructose-1,6-bisphosphate using inorganic pyrophosphate
151                        However, the K(m) for fructose 1,6-bisphosphate was low and the same (0.15 +/-
152 ate and fructose 6-phosphate levels, whereas fructose 1,6-bisphosphate was reduced 2-fold.
153               Small changes in Km values for fructose-1,6-bisphosphate were found in the five mutants
154 ucose-6-phosphate, fructose-6-phosphate, and fructose-1,6-bisphosphate) were profoundly and rapidly e
155 phate, and (ii) phosphofructokinase, to form fructose 1,6-bisphosphate, which is a member of central
156 ut also requires inhibition by the regulator fructose 1,6-bisphosphate, which senses the upper-glycol
157 on is initiated by the glycolytic metabolite fructose-1,6-bisphosphate, which directly binds Cdc19 am
158 e presence of glucose led to accumulation of fructose-1,6-bisphosphate, which has been associated wit
159 te is measured by coupling the production of fructose-1,6-bisphosphate with the oxidation of NADH usi

 
Page Top